Large-scale testing (Phase 3)Study completedNCT01493531What this trial is testingCombining Lesinurad With Allopurinol in Inadequate RespondersWho this might be right forGout Ardea Biosciences, Inc. 610
Post-approval studies (Phase 4)Study completedNCT00424502What this trial is testingMabThera (Rituximab) in Patients With Rheumatoid Arthritis Who Have Had an Inadequate Response to a TNF-Blocker.Who this might be right forRheumatoid Arthritis Hoffmann-La Roche 20
Large-scale testing (Phase 3)Study completedNCT02046616What this trial is testingSubcutaneous (SC) Tocilizumab (RoActemra/Actemra) in Participants With Active Rheumatoid Arthritis (RA) and Inadequate Response to Disease-Modifying Anti-Rheumatic Drugs (DMARDs)Who this might be right forRheumatoid Arthritis Hoffmann-La Roche 133
Large-scale testing (Phase 3)Ended earlyNCT05470985What this trial is testingEvaluate the Efficacy, Safety, and Drug Levels of Oral Ozanimod in Pediatric Participants With Moderately to Severely Active Crohn's Disease With an Inadequate Response to Conventional TherapyWho this might be right forCrohn Disease Bristol-Myers Squibb 5
Large-scale testing (Phase 3)Study completedNCT01838681What this trial is testingBrexpiprazole as Adjunctive Treatment in Patients With Major Depressive Disorder With an Inadequate Response to Antidepressant TreatmentWho this might be right forMajor Depressive Disorder H. Lundbeck A/S 1,986
Post-approval studies (Phase 4)Study completedNCT02466477What this trial is testingPharmacogenomic Decision Support With GeneSight Psychotropic to Guide the Treatment of Major Depressive DisorderWho this might be right forDepressive Disorder, MajorDepressionDepressive Disorder Assurex Health Inc. 542
Post-approval studies (Phase 4)Ended earlyNCT01661140What this trial is testingRoActemra/Actemra (Tocilizumab) in Combination With Methotrexate in Patients With Severe Active Rheumatoid Arthritis, Comparing Tapering Versus Maintaining the Methotrexate DosageWho this might be right forRheumatoid Arthritis Hoffmann-La Roche 427
Large-scale testing (Phase 3)WithdrawnNCT05056779What this trial is testingEfficacy and Safety of Nemolizumab in Subjects With Moderate-to-Severe Atopic Dermatitis With Inadequate Response to or for Whom Cyclosporine A is Not Medically AdvisableWho this might be right forModerate-to-severe Atopic Dermatitis Galderma R&D
Testing effectiveness (Phase 2)Study completedNCT06099535What this trial is testingLNK01001 Capsule in Moderately to Severely Active Rheumatoid ArthritisWho this might be right forRheumatoid Arthritis Lynk Pharmaceuticals Co., Ltd 156
Large-scale testing (Phase 3)Study completedNCT02006706What this trial is testingMabThera/Rituxan (Rituximab) in Combination With Methotrexate in Patients With Rheumatoid Arthritis and Inadequate Response to DMARD TherapyWho this might be right forRheumatoid Arthritis Hoffmann-La Roche 15
Large-scale testing (Phase 3)Study completedNCT01350804What this trial is testingEfficacy at 24 Weeks and Safety, Tolerability and Long Term Efficacy of Secukinumab (AIN457) in Patients With Active Rheumatoid Arthritis (RA) and an Inadequate Response to Anti-Tumor Necrosis Factor α (Anti-TNFα) Agents (CAIN457F2309 and CAIN457F2309E1)Who this might be right forRheumatoid Arthritis Novartis Pharmaceuticals 551
Large-scale testing (Phase 3)Not Yet RecruitingNCT07722611What this trial is testingA Clinical Trial of Bomedemstat in Participants With Polycythemia Vera (MK-3543-025)Who this might be right forPolycythemia Vera Merck Sharp & Dohme LLC 380
Testing effectiveness (Phase 2)Study completedNCT02014363What this trial is testingSafety and Efficacy Study Comparing ETS6103 With Amitriptyline in the Treatment of Major Depressive Disorder (MDD)Who this might be right forMajor Depressive Disorder e-Therapeutics PLC 164
Testing effectiveness (Phase 2)Study completedNCT02955602What this trial is testingSeladelpar (MBX-8025) in Subjects With Primary Biliary Cholangitis (PBC)Who this might be right forPrimary Biliary Cirrhosis Gilead Sciences 119
Testing effectiveness (Phase 2)Study completedNCT05604885What this trial is testingA Dose-range Study of the Safety and Efficacy of Treatment in Adult Rheumatoid Arthritis Patients With an Inadequate Response to MethotrexateWho this might be right forRheumatoid Arthritis SynAct Pharma Aps 125
Testing effectiveness (Phase 2)Study completedNCT01211249What this trial is testingGLPG0259 in Methotrexate-refractory Rheumatoid ArthritisWho this might be right forRheumatoid Arthritis Lakefront Biotherapeutics NV 30
Large-scale testing (Phase 3)Looking for participantsNCT07286058What this trial is testingContinuation Study of Zasocitinib in Adults With Psoriatic ArthritisWho this might be right forPsoriatic Arthritis Takeda 1,182
Large-scale testing (Phase 3)Ended earlyNCT00673920What this trial is testingEvaluate Ocrelizumab Compared With Placebo in Patients With Rheumatoid Arthritis Who Have an Inadequate Response to Methotrexate TherapyWho this might be right forRheumatoid Arthritis Genentech, Inc. 314
Large-scale testing (Phase 3)Looking for participantsNCT07282353What this trial is testingCS0159 in Patients With PBC With Inadequate Response or Intolerance to UDCAWho this might be right forPrimary Biliary Cholangitis Cascade Pharmaceuticals, Inc 135
Testing effectiveness (Phase 2)Study completedNCT00430495What this trial is testingDose-finding Study of Atacicept in Subjects With Rheumatoid Arthritis (AUGUST I)Who this might be right forRheumatoid Arthritis EMD Serono 256